| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.32 | 3e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.27 | 3e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.34 | 9e-08 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |